Orthofix Medical Inc.

NASDAQ:OFIX

Medical - Devices

Healthcare
$6.61 +0.33%

+$0.03 today

Market cap
$269.42M
Beta
0.71
P/E (TTM)
-6.2
EPS (TTM)
-$1.48
52W Low $9.12High $16.99

Volume 0.40M

Average 0.38M

OFIX Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Orthofix Medical Inc.NASDAQ: OFIX

Revenue · Q1 FY2026 · quarter ended Mar 2026

Revenue grows in line with its trailing trend

Q1 FY2026 revenue of $196.71M rose 1.6% year over year, behind the +2.6% change in trailing-twelve-month revenue. Sequentially, it fell 10.6% from the prior quarter. Over 3 fiscal years it compounded at +21.3% a year.

Context

  • Revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 3 analysts of $827.09M (+0.6%) for the fiscal year ending Dec 2026, a slowdown from the +2.9% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$196.71M-10.6% QoQ
Last fiscal yearDec 2025
$822.31M+2.9% YoY
LTMMar 2026
$825.37M+2.6% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.6%+3.0%+1.4 pp
1 year+2.9%+0.6%-2.3 pp
3-year CAGR+21.3%+2.3%-19.0 pp
5-year CAGR+5.1%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
822.31M USD
Year-over-year change
+2.9%
4-year CAGR
+15.4%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How OFIX compares with its peers on the latest reported figures

  • OFIX's LTM Mar 2026 revenue of $825.37M is the 2nd highest of the 11 companies compared; the peer median is $131.47M.
  • Its year-over-year change of +2.6% is the 7th highest of 10, against a peer median of +3.9%.
  • Over three fiscal years its annual growth of +21.3% compares with a peer median of +0.8%.
OFIX Competitors Peer median
Revenue for OFIX and competitors
Company Period LTM YoY 3-year CAGR
VREXVarex Imaging CorporationLTM Apr 2026$857.5M +3.6%-0.6%
OFIXOrthofix Medical Inc.LTM Mar 2026$825.37M +2.6%+21.3%
AVNSAvanos Medical, Inc.LTM Mar 2026$715.9M +3.9%+0.8%
ESPREsperion Therapeutics, Inc.LTM Mar 2026$418.24M +61.1%+74.8%
SIBNSI-BONE, Inc.LTM Mar 2026$206.22M +16.8%+23.6%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$160.03M +5.0%+7.6%
BFLYButterfly Network, Inc.LTM Mar 2026$102.92M +20.2%+10.0%
LABStandard BioTools Inc.LTM Mar 2026$86.26M -35.8%-4.5%
DRIODarioHealth Corp.LTM Mar 2026$21.19M -24.4%-6.8%
ABSIAbsci CorporationLTM Mar 2026$1.84M -61.9%-21.3%
MLTXMoonLake ImmunotherapeuticsLTM Mar 2026$0 ——
Peer median (excluding OFIX) $131.47M+3.9%+0.8%

Competitors are the stored peer set for OFIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue464.48M460.71M746.64M799.49M822.31M
Cost of Revenue114.91M123.54M260.37M253.61M270.61M
Gross Profit349.57M337.17M486.27M545.89M551.71M
Gross Margin75.3%73.2%65.1%68.3%67.1%
Research & Development49.62M49.07M80.23M73.64M57.11M
Selling, General & Admin290.67M308.78M530.4M532.53M456.39M
Operating Expenses357.88M350.44M625.38M630.5M620.18M
Depreciation & Amortization33.1M32.08M60.56M60.06M50.97M
EBITDA21.44M15.66M(79.49M)(34.18M)(22.35M)
EBITDA Margin4.6%3.4%-10.6%-4.3%-2.7%
Operating Income(8.32M)(13.27M)(139.11M)(84.62M)(68.47M)
Operating Margin-1.8%-2.9%-18.6%-10.6%-8.3%
Interest Income00000
Interest Expense1.84M1.29M8.63M29.63M17.49M
Other Income / Expenses(5.18M)(4.44M)(9.57M)(39.26M)(22.34M)
Income Before Tax(13.5M)(17.71M)(148.68M)(123.88M)(90.81M)
Pre-Tax Margin-2.9%-3.8%-19.9%-15.5%-11.0%
Income Tax Expense24.88M2.04M2.72M2.12M1.38M
Net Income(38.38M)(19.75M)(151.4M)(126M)(92.19M)
Net Margin-8.3%-4.3%-20.3%-15.8%-11.2%
EPS (Basic)(1.95)(0.98)(4.12)(3.30)(2.28)
EPS (Diluted)(1.95)(0.98)(4.12)(3.30)(2.28)
Weighted Avg Shares19.69M20.1M36.73M38.13M39.88M
Weighted Avg Shares (Diluted)19.69M20.1M36.73M38.13M39.88M

Orthofix Medical Inc.

NASDAQ:OFIX

Intrinsic Alpha fair value

Locked

Current Price

$6.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.